© 1999 American Heart Association, Inc.
Original Contribution |
Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization
From the Departments of Medicine (Cardiology) and Biomedical Research, St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass.
Correspondence to Jeffrey M. Isner, MD, or Takayuki Asahara, MD, St Elizabeth's Medical Center, 736 Cambridge St, Boston, MA 02135. E-mail jisner@opal.tufts.edu or asa777{at}aol.com
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Abstract—Circulating endothelial progenitor cells (EPCs) have been isolated in peripheral blood of adult species. To determine the origin and role of EPCs contributing to postnatal vasculogenesis, transgenic mice constitutively expressing ß-galactosidase under the transcriptional regulation of an endothelial cell–specific promoter (Flk-1/LZ or Tie-2/LZ) were used as transplant donors. Localization of EPCs, indicated by flk-1 or tie-2/lacZ fusion transcripts, were identified in corpus luteal and endometrial neovasculature after inductive ovulation. Mouse syngeneic colon cancer cells (MCA38) were implanted subcutaneously into Flk-1/LZ/BMT (bone marrow transplantation) and Tie-2/LZ/BMT mice; tumor samples harvested at 1 week disclosed abundant flk-1/lacZ and tie-2/lacZ fusion transcripts, and sections stained with X-gal demonstrated that the neovasculature of the developing tumor frequently comprised Flk-1– or Tie-2–expressing EPCs. Cutaneous wounds examined at 4 days and 7 days after skin removal by punch biopsy disclosed EPCs incorporated into foci of neovascularization at high frequency. One week after the onset of hindlimb ischemia, lacZ-positive EPCs were identified incorporated into capillaries among skeletal myocytes. After permanent ligation of the left anterior descending coronary artery, histological samples from sites of myocardial infarction demonstrated incorporation of EPCs into foci of neovascularization at the border of the infarct. These findings indicate that postnatal neovascularization does not rely exclusively on sprouting from preexisting blood vessels (angiogenesis); instead, EPCs circulate from bone marrow to incorporate into and thus contribute to postnatal physiological and pathological neovascularization, which is consistent with postnatal vasculogenesis.
Key Words: vasculogenesis • endothelial progenitor cell • bone marrow transplantation • Flk-1 • Tie-2
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
In the embryonic yolk sac, vasculogenesis involves growth and fusion of multiple blood islands that ultimately give rise to the yolk sac capillary network1 ; after the onset of blood circulation, this network differentiates into an arteriovenous vascular system.2 The integral relationship between the elements that circulate in the vascular system (the blood cells) and the cells that are principally responsible for the vessels themselves (endothelial cells [ECs]) is implied by the composition of the embryonic blood islands. The cells destined to generate hematopoietic cells are situated in the center of the blood island and are termed hematopoietic stem cells. Endothelial progenitor cells (EPCs), or angioblasts, are located at the periphery of the blood islands. In addition to this spatial association, hematopoietic stem cells and EPCs share certain antigenic determinants, including Flk-1, Tie-2, Sca-1, and CD34. These progenitor cells have consequently been considered to derive from a common precursor, putatively termed a hemangioblast.3 4 5
Circulating CD34 antigen–positive EPCs were recently isolated from adult species; once adherent, these cells were shown to differentiate in vitro.6 Heterologous, homologous, or autologous EPCs administered systemically to animals with operatively induced hindlimb ischemia were found to incorporate into foci of neovascularization in ischemic muscles of the affected hindlimb. These findings, together with other recent studies,7 8 9 are consistent with the notion of postnatal "vasculogenesis."2 10
To determine the origin and role of EPCs contributing to postnatal vasculogenesis, we established 2 murine models of bone marrow transplantation (BMT). In each case, immune-deficient mice underwent BMT from transgenic mice constitutively expressing ß-galactosidase (lacZ) transcriptionally regulated by an EC-specific promoter, Flk-1 or Tie-2. Reconstitution of the transplanted BM yielded Flk-1/LZ/BMT or Tie-2/LZ/BMT mice, in which expression of lacZ is restricted to BM cells expressing Flk-1 or Tie-2; lacZ expression is not observed in other somatic cells. We then sought evidence of lacZ expression and the promoter/lacZ transcripts, flk-1/lacZ and tie-2/lacZ, in both pathological and physiological neovascular foci as a means of assessing the contribution of BM-derived EPCs to postnatal neovascularization.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Murine BMT Model
All protocols were approved by the St Elizabeth's Medical Center Institutional Animal Care and Use Committee. In the present study, we established 2 BMT animal models: Flk-1/LZ/BMT mice, which received BM from mice heterozygous for flk-1 null mutation, and Tie-2/LZ/BMT mice, which received BM from transgenic mice constitutively overexpressing ß-galactosidase (lacZ) regulated by the Tie-2 promoter. In the flk-1 null mutation, the target gene was replaced with a promoterless lacZ gene from Escherichia coli so that in the heterozygous mouse, expression of lacZ as well as target receptor protein (Flk-1) is subject to regulation by an EC-specific promoter.
BM cells were obtained by flushing the tibias and femurs of age-matched (4 weeks) donor mice heterozygous for Flk-1–null mutation (generous gift from Dr F. Shalaby, Bristol-Myers Squibb Pharmaceutical Research, Princeton, NJ) or Tie-2 transgenic mice (FVB/N-TgN[TIE2LacZ]182Sato, The Jackson Laboratory, Bar Harbor, Maine). BMT from C57BL/6J mice, C/BMT, were used as negative controls. BMT in lacZ-overexpressing (LZ/BMT) mice (B6,129-TgR[ROSA26]26Sor, The Jackson Laboratory) was also performed to investigate the efficiency of BMT.
Low-density BM mononuclear cells were isolated by density
centrifugation over Histopaque-1083 (Sigma). The
immunodeficient mice, NIH-III (Tac:NIHS-bg-nu-xidfDF, Taconic Farms,
Germantown, NY), were lethally irradiated with 9.0 Gy and received
2x106 donor BM mononuclear cells each
intravenously. At 4 weeks post-BMT, by which time the BM of
the recipient mice is reconstituted, a variety of surgical experiments
were performed. Organs of normal BMT animals and pathological tissues
from BMT experimental animal models were harvested for isolation of
mRNA and cellular identification of lacZ after intracardial perfusion
of phosphate-buffered salt solution to avoid blood cell contamination.
In the case of histological examination for
identification of lacZ-expressing cells, 1%
paraformaldehyde solution was perfused as well.
To determine the transplant efficiency of LZ/BMT, low-density BM mononuclear cells were isolated and cultured for methylcellulose semisolid culture assay (MethoCult M3630, StemCell Tech). BM mononuclear cells (1.0x105) were cultured in a 35-mm methylcellulose well for 12 days, after which colonies were stained with X-gal solution for 3 hours and then counted by light microscopic examination.
Hormone-Induced Ovulation
To obtain hormone-induced ovulation, 5 IU of pregnant mare serum
gonadotropin (Sigma) was injected intraperitoneally
4 weeks after BMT, followed 42 hours later by 5 IU of human chorionic
gonadotropin. The mice were killed, and the ovary and uterus were
surgically removed at 48 to 72 hours after gonadotropin
administration.
Tumor Implantation Model
BMT mice were anesthetized with pentobarbital (160 mg/kg
IP). Approximately 2x106 mouse syngeneic colon
cancer cells (MCA38) were suspended in 100 µL of Matrigel and
injected subcutaneously at the flank fold. Large tumors were typically
observed 3 to 4 weeks after implantation. Mice were euthanized at 1
week or 3 weeks after macroscopic tumor identification, and sections of
the tumor and surrounding tissue were harvested for
histological analysis.
Wound Healing Model
The skin was cleansed with 70% alcohol, and a full-thickness
wound was made by pinching up a fold of flank skin and using a sterile,
disposable 4-mm punch biopsy (Baker Cummins Dermatological) to punch
through the 2 layers of skin on one flank. At various intervals after
wounding, the mice were euthanized, and wounds were harvested with a
perimeter of 1 to 2 mm of normal skin tissue and analyzed
for EPC incorporation into wound neovasculature.
Murine Ischemic Hindlimb Model
The murine model of hindlimb ischemia used for these
experiments was based on that previously described by Couffinhal et
al.11 Skin incision was performed at the middle portion of
the left hindlimb overlying the femoral artery. The femoral artery then
was gently isolated, and the proximal portion of the femoral artery was
ligated with a 3-0 silk ligature. The distal portion of the saphenous
artery was ligated, and other arterial branches as well as
veins were all dissected free and excised. The overlying skin was
closed using 2 surgical staples. After surgery, mice were kept on a
heating plate at 37°C, and special care was taken to monitor the
animals until they had completely recovered from
anesthesia.
Myocardial Ischemia Model
The mouse model of myocardial ischemia was based on that
previously described by Michael et al.12 Mice were
anesthetized, placed in a position rotated 45° to the right
of supine, and cannulated with a 22-gauge IV catheter (Johnson &
Johnson), and the intubation cannula was connected to the output valve
of a mouse ventilator (Harvard Apparatus). The ventilator
typically delivered to the mouse a volume of 0.2 to 0.5 mL, 100%
O2, at a rate of 115 strokes per minute. An
incision was then made along the left midclavicular line and, using a
dissecting microscope, the pectoralis muscle was dissected. A lateral
incision was made in the left fourth intercostal space, and the ribs
were retracted to open the chest. After removal of pericardium, the
left anterior descending (LAD) branch of the left coronary
artery was identified under high-power magnification. The LAD was then
permanently ligated by passing an 8-0 silk suture under the LAD at the
level of the distal margin of the retracted left atrial appendage. The
chest wall, muscle layers, and skin were then closed with interrupted
6-0 silk sutures, intubation was discontinued, and the mice were
allowed to recover on a heated platform.
Identification of flk-1/lacZ or tie-2/lacZTranscripts
RNA was extracted from each tissue sample using a total RNA
isolation kit (Totally RNA, Ambion Inc). One microgram of total RNA
from each sample underwent reverse transcriptase–polymerase chain
reaction (RT-PCR) after DNase treatment. Reverse transcription and PCR
were respectively performed using a Superscript Preamplification System
kit (GIBCO-BRL) and Gene Amp PCR reagent kit with Amplitaq DNA
polymerase (Perkin Elmer Corp), according to the supplemented
protocol.
Primer pairs for the amplification of flk-1/lacZ or tie-2/lacZ reverse-transcribed products13 14 were as follows: 5'-CTG TGT CCC GCA GCC GGA TA-3' and 1:5'-AAA GCG CCA TTC GCC ATT CA-3' (flk-1/lacZ) and 5'-GGG AAG TCG CAA AGT TGT GAG TT-3' and 5'-CGT GGC CTG ATT CAT TCC-3' (tie-2/lacZ).
Twelve microliters of each PCR mixture was electrophoresed in 2% or 1% agarose gel containing ethidium bromide for flk-1/lacZ and tie-2/lacZ, respectively. RT-PCR products were photographed under a UV transilluminator.
Cellular Identification of lacZ-Expressing Cells
After completing the in vivo experiment, mice were euthanized
and the target organs fixed with 4% paraformaldehyde
for 3 hours at 4°C and incubated in X-gal solution overnight at
37°C. The tissue samples were then placed in PBS and examined under a
dissecting microscope to localize foci of lacZ-expressing cells.
Histological sections were counterstained with light
hematoxylin and eosin and examined by light microscopy. The control
samples from C/BMT mice were examined identically.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Physiological Neovascularization
The efficiency of BMT was assessed by X-gal staining of cell colonies in a methylcellulose colony assay using BM mononuclear cells isolated from LZ/BMT mice. LacZ-expressing donor-derived cells were identified in 92.6±4.2% of BM colonies.
Physiological localization of EPCs to normal (ie,
unperturbed) organs was investigated using RT-PCR to identify
flk-1/lacZ and tie-2/lacZ fusion transcripts
(Figure 1
). Each transcript was indeed
detected abundantly in BM, peripheral blood, spleen, and to
a lesser extent in lung, liver, intestine, skin, and hindlimb muscle,
as well as ovary and uterus. Such constitutive incorporation of
BM-derived Flk-1– and Tie-2–expressing cells into these normal organs
implies a role for EPCs in physiological organ
maintenance. The absence of EPC incorporation into the brain
are consistent with findings of Pereira et
al15 and may reflect organ-specific differences in
vascular and connective tissue structure.
|
The development and endocrine function of the ovarian corpus luteum have been shown to depend on the development of new vessels.16 17 To show evidence for vasculogenesis in physiological neovascularization of the ovaries and endometrium, ovarian cycling was hormonally induced in Flk-1/LZ/BMT or Tie-2/LZ/BMT mice. The sequence of events that follows ovulation in this model is essentially the same as that occurring during spontaneous cycling, because induction typically results in functional luteal development and pregnancy.
Histological examination of the harvested ovaries
disclosed X-gal–stained, BM-derived Flk-1– and Tie-2–expressing
cells in the corpus lutea (Figure 2B).
Histological sections taken from the uterus also showed
X-gal–stained vasculature as well as isolated cells in the endometrium
and stroma (Figure 2C and 2D). The findings indicate that EPCs
contribute to physiological neovascularization
associated with postnatal regenerative processes.
|
Pathological Neovascularization
Tumor
Pathological neovascularization accompanying tumor growth, wound
healing, hindlimb ischemia, and myocardial infarction were
evaluated for incorporation of EPCs in the above-described murine BMT
models. Mouse syngeneic colon cancer cells (MCA38) were implanted
subcutaneously into Flk-1/LZ/BMT and Tie-2/LZ/BMT mice and harvested at
1 week or 3 weeks after macroscopic tumor identification. The
flk-1/lacZ and tie-2/lacZ fusion transcripts were
detected in abundance in tumor samples (Figure 3). Tumor tissues stained with X-gal
demonstrated that the neovasculature of the developing tumor frequently
comprised Flk-1– or Tie-2–expressing EPCs (Figure 4). EPCs were localized focally in highly
vascularized lesions, particularly at the tumor periphery; EPCs were
incorporated into capillaries and were identified as stromal cells
adjacent to the neovasculature as well. A linear configuration of
BM-derived EPCs was observed frequently. The frequency and distribution
of EPCs were consistent within the tumor periphery between 1
week and 3 weeks after macroscopic tumor growth, although at 3 weeks,
EPCs were absent from central necrotic foci. No lacZ-stained cells were
found in tumor tissues from control BMT animals (C/BMT mice).
|
|
Wound Healing
Healing of cutaneous wounds was examined at 4 days, 7 days, and 4
weeks after skin removal by punch biopsy. At 4 and 7 days,
lacZ-positive BN-derived EPCs were incorporated into foci of
neovascularization at high frequency (Figure 5). Neovasculature and stromal cells
consisting of EPCs were observed mainly in granulation and fat tissues.
Flk-1– and Tie-2–expressing EPCs were observed with equal frequency
in these tissues. At 4 weeks after wounding, negligible X-gal–stained
EPCs could be identified. This was confirmed by down-regulation of
promoter/lacZ transcript expression in these tissues (Figure 3
).
|
Limb and Myocardial Ischemia
Evidence that vasculogenesis constitutes a reparatory response to
tissue ischemia was observed as well. Unilateral hindlimb
ischemia was established in mice by surgical excision of one
femoral artery.11 One week after the onset of hindlimb
ischemia, Tie-2– or Flk-1–expressing lacZ-positive EPC
colonies were observed in tissue stroma at sites of ischemia,
and lacZ-positive EPCs were identified incorporated into capillaries
among myocytes (Figure 6A and 6B). At 4
weeks after ischemia, EPCs were observed incorporated into
capillaries and interstitial arteries (Figure 6C) at
the periphery of the ischemic foci.
|
After permanent ligation of the LAD coronary
artery,12 histological samples from sites
of myocardial infarction were retrieved from BMT mice. Light
photomicrographs demonstrated incorporation of EPCs into foci of
neovascularization at the border of the infarct, confirmed by
immunostaining for CD31 in sections of
myocardium harvested at 1 week after infarction (Figure 6D and 6E).
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
This series of BMT experiments establishes proof of the concept that postnatal vasculogenesis contributes to endogenous neovascularization of developing tumors, wound healing, severe hindlimb ischemia, and myocardial ischemia, as well as physiological neovascularization.
BMT recipients received BM from transgenic mice in which constitutive lacZ expression was regulated by an EC-specific promoter, Flk-1 or Tie-2. Vascular endothelial growth factor, the cognate ligand for the EC-specific tyrosine kinase receptor (TKR) Flk-1, has been shown to be essential for EPC (angioblast) differentiation and blood vessel development during embryogenesis13 18 and postnatal neovascularization.19 20 21 22 23 The Tie receptors, Tie-1 and Tie-2, constitute a second family of EC-specific TKRs. Tie-2 receptor has been shown to be expressed in endothelial lineage cells participating in angiogenesis24 25 and, in this regard, essential for blood vessel development and maturation.14 26
Physiological localization of EPCs to normal organs
was detected using RT-PCR to identify flk-1/lacZ and
tie-2/lacZ fusion transcripts. Each transcript was indeed
detected abundantly in BM, peripheral blood, spleen, and to
a lesser extent in lung, liver, intestine, skin, and hindlimb muscle,
as well as ovary and uterus. Such constitutive incorporation of
BM-derived Flk-1– and Tie-2–expressing cells into these normal organs
implies a role for EPCs in physiological organ
maintenance. The concept of BM-derived progenitor cell
reservoirs in normal tissues is consistent with the notion of
BM-derived satellite myoblasts and mesenchymal stem cells in muscle or
other normal organs.15 27 Isolated lacZ-positive EPCs
were indeed located at interstitial sites among muscle
fibers of healthy hindlimb muscle (Figure 2A). The mouse
hindlimb muscle is a highly energy-consuming and
physiologically stressed organ. Circulating
BM-derived EPCs may home to tissue stroma in certain organs for the
purpose of providing maintenance reservoirs of ECs analogous to
satellite myoblasts and fibroblasts. The current findings extend this
concept to physiological organogenesis in the
reproductive system.
The hormonally induced ovulation cycles were associated with upregulated ovarian expression of flk-1/lacZ and tie-2/lacZ. Histological examination of the harvested reproduction systems disclosed BM-derived Flk-1– and Tie-2–expressing cells in corpus lutea and in the uterus endometrium and stroma. The findings indicate that EPCs contribute to physiological neovascularization associated with postnatal regenerative processes. Detection of flk-1/lacZ and tie-2/lacZ transcripts indicates natural homing of EPCs to organs devoid of pathological alterations and, in the case of the ovary and endometrium, characterized by cyclic, physiological neovascularization. In these tissues, cyclic neovascularization is associated with abundant expression of angiogenic growth factors,28 including vascular endothelial growth factor,17 29 basic fibroblast growth factor,30 and angiopoietins.31 These cytokines, together with as-yet-unidentified cell adhesion molecules and supportive stromal cells, likely contribute to enhanced homing of circulating EPCs to corpus lutea and endometrial tissue, in which they may further differentiate and/or incorporate into foci of neovascularization.
EPCs expressing Flk-1 or Tie-2 were found incorporated into the nascent vasculature of these respective pathological lesions. Indeed, not only were EPCs identified incorporated into blood vessels, but lacZ-positive colonies or isolated lacZ-positive cells were frequently observed in stroma of tumors, ischemic hindlimbs, and sites of wound healing. This finding is consistent with the recent finding of BM-derived mesenchymal stem cells.32 BMT experiments performed by Pereira et al15 suggest that mesenchymal stem cells in BM serve as a continuing source for a variety of mesenchymal cells, such as fibroblasts, osteoblasts, chondroblasts, adipocytes, and myoblasts. More recently, Ferrari et al27 showed evidence of muscle regeneration from BM-derived myogenic progenitors using BMT experiments similar to those described here. Their data, together with ours, suggest that vascular endothelium as well as mesenchymal cells may be derived from BM and contribute to organ regeneration and maintenance.
The growth of tumors to a clinically relevant size is dependent on an adequate blood supply.33 34 This is achieved by the process of tumor stroma generation in which the formation of new capillaries is a central event.35 36 Several molecular and cellular mechanisms have been identified by which tumor parenchyma may exert angiogenic effects on ECs.37 38 As a result of this paracrine influence, tumor-associated ECs have been considered to acquire an "immature" phenotype manifested by rapid proliferation, migration, release of proteases, and expression of EC-specific TKRs (eg, Flk-1, Tie-2, or Tie-1). This is not only the case with tumors. Wound healing as well as severely ischemic muscles and myocardium evolve abundant stroma and neovasculature after paracrine and autocrine expression of angiogenic cytokines.36 39 40
BM-derived EPCs were observed within tissue stroma at sites of pathological neovascularization. On the basis of the expression patterns of EPCs during embryogenesis, EPCs in postnatal stromal tissues would be anticipated to proliferate, differentiate, and migrate in situ in the process of neovascularization. In stromal tissues, after the inflammatory response of extravasated blood cells such as platelets and monocyte/macrophage-delivering cytokines, EC-like or fibroblast-like cells follow closely behind for neovascularization.36 As Hatva et al41 have shown, a subpopulation of cells in hemangioblastoma stroma express Flk-1, Flt-1, and Tie-1 receptors. These observations are consistent with the notion that EPCs home to and differentiate in the stromal environment of tumors, ischemic muscles, and sites of wound healing, presumably for the purpose of promoting neovascularization.
The temporal sequence associated with pathological vasculogenesis in these BMT models varied according to the pathological state. In the case of a neoplasm, a period of 1 to 3 weeks after initiation of the so-called angiogenic switch34 is characterized by persistence of the initial stage of neovascularization, including cellular differentiation and development of neovascular sprouts rather than vessel maturation or regression; such persistent vasculogenesis is reminiscent of Dvorak's36 characterization of tumors as "wounds that do not heal." In contrast, neovascularization of the ischemic hindlimb at 1 week includes lacZ-positive EPC colonization and sprouting, but by 4 weeks demonstrates a marked increase in capillary density and arteries. This suggests that ischemia initiates sequential stages from initial vasculogenesis to maturation of blood vessels required for persistent collateral circulation. In the wound healing model, after an initial stage of potent neovascularization, most of the neovasculature composed of EPCs undergoes regression leading to scar tissue.
The expression of lacZ regulated by Flk-1 and Tie-2 promoters could potentially identify both BM-derived differentiated ECs and EPCs. The lack of an epitope of which the expression is restricted exclusively to either fully differentiated ECs or EPCs makes it difficult to resolve this issue simply on the basis of cell sorting. There are at least 3 lines of evidence, however, that suggest that EPCs constitute the preponderance of such circulating BM-derived endothelial lineage cells. First, previous work has shown that freshly isolated CD34-positive cells display a paucity of EC-specific markers, in contrast to plated cells cultured for 7 days.6 Second, recent work from our own laboratory has shown that in contrast to EPCs, heterologously transplanted differentiated ECs rarely incorporate into foci of neovascularization.42 Third, previous work6 7 8 indicates that the population of circulating EPCs far exceeds the number of differentiated ECs in peripheral blood.43 44
These findings underscore the notion that postnatal neovascularization is not synonymous with angiogenesis, at least as the latter has been classically defined, to consist of sprouts that originate as the result of proliferation and migration of differentiated ECs from parent vessels. The current findings indicate that BM-derived EPCs home to and incorporate into sites of neovascularization where differentiation into ECs is completed, which is consistent with postnatal vasculogenesis. As a corollary, augmented or retarded neovascularization, whether endogenous or iatrogenic, likely includes enhancement or impairment of vasculogenesis.
|
Acknowledgments |
|---|
This work was supported by Grants HL40518, HL02824, and HL57516 (to J.M.I.) from the NIH (Bethesda, Md). C.K. is supported in part by Cologne Fortune in Germany. We thank M. Neely for secretarial assistance. The Flk-1-null mutation was a generous gift from Dr F. Shalaby of Bristol-Myers Squibb Pharmaceutical Research, and the MCA38 cell line was a generous gift from Dr H. Takahashi of Harvard Medical School (Cambridge, Mass).
Received March 11, 1999; accepted May 25, 1999.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
1. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol. 1995;11:73–91.[Medline] [Order article via Infotrieve]
2. Risau W, Sariola H, Zerwes H-G, Sasse J, Ekblom P, Kemler R, Doetschman T. Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies. Development. 1988;102:471–478.[Abstract]
3. Flamme I, Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development. 1992;116:435–439.[Medline] [Order article via Infotrieve]
4. His W. Leoithoblast und angioblast der wirbelthiere. Abhandl K S Ges Wiss Math Phys. 1900;22:171–328.
5. Weiss M, Orkin SH. In vitro differentiation of murine embryonic stem cells: new approaches to old problems. J Clin Invest. 1996;97:591–595.[Medline] [Order article via Infotrieve]
6. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:965–967.
7.
Shi Q, Rafii S, Wu MH-D, Wijelath ES, Yu C, Ishida A,
Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MAS, Storb RF, Hammond
WP. Evidence for circulating bone marrow-derived
endothelial cells. Blood. 1998;92:362–367.
8. Hatzopoulos AK, Folkman J, Vasile E, Eiselen GK, Rosenberg RD. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development. 1998;125:1457–1468.[Abstract]
9. Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. VEGF gene delivery to muscle: potential role of vasculogenesis in adults. Mol Cell. 1998;2:549–558.[Medline] [Order article via Infotrieve]
10.
Pardanaud L, Altman C, Kitos P, Dieterien-Lievre F.
Relationship between vasculogenesis, angiogenesis and haemopoiesis
during avian ontogeny. Development. 1989;105:473–485.
11. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. A mouse model of angiogenesis. Am J Pathol. 1998;152:1667–1679.[Abstract]
12.
Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J,
Hall SR, Hawkins HK, Berens K, Ballantyne CM. Myocardial
ischemia and reperfusion: a murine model. Am J
Physiol. 1995;269:H2147–H2154.
13. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu X-F, Breitman ML, Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature. 1995;376:62–66.[Medline] [Order article via Infotrieve]
14. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gentron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 1995;376:70–74.[Medline] [Order article via Infotrieve]
15.
Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov
BP, Pollard MD, Bagasra O, Prockop DJ. Cultured adherent cells from
marrow can serve as long-lasting precursor cells for bone, cartilage,
and lung in irradiated mice. Proc Natl Acad Sci U S A. 1995;92:4857–4861.
16. Bassett DEL. The changes in the vascular pattern of the ovary of the albino rat during the estrous cycle. Am J Anat. 1943;73:251–278.
17. Ferrara N, Chen H, David-Smith T, Gerber HP, Nguyen TN, Peers D, Chisholm V, Hillan KJ, Schwall RH. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med. 1998;4:336–340.[Medline] [Order article via Infotrieve]
18. Fong G-H, Rossant J, Gersenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 1995;376:66–70.[Medline] [Order article via Infotrieve]
19. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest. 1994;93:662–670.
20. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes J. Clinical evidence of angiogenesis following arterial gene transfer of phVEGF165. Lancet. 1996;348:370–374.[Medline] [Order article via Infotrieve]
21.
Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz
M, Biro S, Epstein SE, Unger EF. Angiogenic-induced enhancement of
collateral blood flow to ischemic myocardium by
vascular endothelial growth factor in dogs.
Circulation. 1994;89:2183–2189.
22. Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladston SR, Friedman M, Sellke FW, Simons M. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med. 1995;1:1085–1089.[Medline] [Order article via Infotrieve]
23.
Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP,
Simons M. VEGF, flk-1, and flt-1 expression in a
rat myocardial infarction model of angiogenesis. Am J
Physiol. 1996;270:H1803–H1811.
24. Schnurch H, Risau W. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development. 1993;119:957–968.[Abstract]
25. Dumont DJ, Fong G-H, Fong MC, Puri G, Gradwohl G, Alitalo K, Breitman ML. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn. 1995;203:80–92.[Medline] [Order article via Infotrieve]
26.
Dumont DJ, Gradwohl G, Guo-Hua F, Puri MC, Gertsenstein
M, Auerbach A, Breitman ML. Dominant-negative and targeted null
mutations in the endothelial receptor tyrosine kinase,
tek, reveal a critical role in vasculogenesis of the embryo.
Genes Dev. 1994;8:1897–1909.
27.
Ferrari G, Angelis GCD, Coletta M, Paolucci E,
Stornaiuolo A, Gossu G, Mavilio F. Muscle regeneration by bone
marrow-derived myogenic progenitors. Science. 1998;279:1528–1530.
28.
Gospodarowicz D, Takral TK. Production of
a corpus luteum angiogenic growth factor responsible for proliferation
of capillaries and neovascularization of the corpus luteum. Proc
Natl Acad Sci U S A. 1978;75:847–851.
29. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun. 1989;161:851–855.[Medline] [Order article via Infotrieve]
30.
Ferrara N, Schweigerer L, Neufeld G, Mitchell R,
Gospodarowicz D. Pituitary follicular cells produce basic fibroblast
growth factor. Proc Natl Acad Sci U S A. 1987;84:5773–5777.
31.
Maisonpierre P, Suri C, Jones P, Bartunkova S, Wiegand
S, Radziejewski C, Compton D, McClain J, Aldrich T, Papadopoulos N,
Daly T, Davis S, Sato T, Yancopoulos G. Angiopoietin-2, a natural
antagonist for Tie2 that disrupts in vivo angiogenesis.
Science. 1997;277:55–60.
32.
Prokop DJ. Marrow stromal cells as stem cells for
nonhematopoietic tissues. Science. 1997;276:71–74.
33. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182–1186.
34. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353–364.[Medline] [Order article via Infotrieve]
35. Folkman J. Toward an understanding of angiogenesis: search and discovery. Perspect Biol Med. 1985;29:10–36.[Medline] [Order article via Infotrieve]
36. Dvorak HF. Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315:1650–1659.[Medline] [Order article via Infotrieve]
37.
Folkman J, Klagsbrun M. Angiogenic factors.
Science. 1987;235:442–447.
38.
Folkman J, Shing Y. Angiogenesis. J Biol
Chem. 1992;267:10931–10934.
39. Isner JM. The role of angiogenic cytokines in cardiovascular disease. Clin Immunol Immunopathol. 1996;80:S82–S91.[Medline] [Order article via Infotrieve]
40. Ware JA, Simons M. Angiogenesis in ischemic heart disease. Nat Med. 1997;3:158–164.[Medline] [Order article via Infotrieve]
41. Hatva E, Bohling T, Jaaskelainen J, Perssico MG, Haltia M, Alitalo K. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol. 1996;148:763–775.[Abstract]
42. Kalka C, Masuda H, Takahashi T, Li T, Asahara T. Administration of culture-expanded endothelial progenitor cells (EPC) augments therapeutic neovascularization. Circulation. 1998;97 (suppl I):I-455. Abstract.
43. Peretz D, Gitay-Goren H, Safran M, Kimmel N, Gospodarowicz D, Neufeld G. Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity. Biochem Biophys Res Commun. 1992;182:1340–1347.[Medline] [Order article via Infotrieve]
44. Solovey A, Lin Y, Brown P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med. 1997;337:1582–1590.
This article has been cited by other articles:
 |
|
 |
|
  L. Li, H. Okada, G. Takemura, M. Esaki, H. Kobayashi, H. Kanamori, I. Kawamura, R. Maruyama, T. Fujiwara, H. Fujiwara, et al. Sustained Release of Erythropoietin Using Biodegradable Gelatin Hydrogel Microspheres Persistently Improves Lower Leg Ischemia J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2378 - 2388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Moriya, T. Minamino, K. Tateno, N. Shimizu, Y. Kuwabara, Y. Sato, Y. Saito, and I. Komuro Long-Term Outcome of Therapeutic Neovascularization Using Peripheral Blood Mononuclear Cells for Limb Ischemia Circ Cardiovasc Intervent, June 1, 2009; 2(3): 245 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Capoccia, D. L. Robson, K. D. Levac, D. J. Maxwell, S. A. Hohm, M. J. Neelamkavil, G. I. Bell, A. Xenocostas, D. C. Link, D. Piwnica-Worms, et al. Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity Blood, May 21, 2009; 113(21): 5340 - 5351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hamid and J. H. Newman Evidence for Inflammatory Signaling in Idiopathic Pulmonary Artery Hypertension: TRPC6 and Nuclear Factor-{kappa}B Circulation, May 5, 2009; 119(17): 2297 - 2298. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chakroborty, C. Sarkar, B. Basu, P. S. Dasgupta, and S. Basu Catecholamines Regulate Tumor Angiogenesis Cancer Res., May 1, 2009; 69(9): 3727 - 3730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-M. Kwon, T. Suzuki, A. Kawamoto, M. Ii, M. Eguchi, H. Akimaru, M. Wada, T. Matsumoto, H. Masuda, Y. Nakagawa, et al. Pivotal Role of Lnk Adaptor Protein in Endothelial Progenitor Cell Biology for Vascular Regeneration Circ. Res., April 24, 2009; 104(8): 969 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhang, L. Ding, Y. Zhao, W. Sun, B. Chen, H. Lin, X. Wang, L. Zhang, B. Xu, and J. Dai Collagen-Targeting Vascular Endothelial Growth Factor Improves Cardiac Performance After Myocardial Infarction Circulation, April 7, 2009; 119(13): 1776 - 1784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Shi, M. Ishikawa, N. Kamei, T. Nakasa, N. Adachi, M. Deie, T. Asahara, and M. Ochi Acceleration of Skeletal Muscle Regeneration in a Rat Skeletal Muscle Injury Model by Local Injection of Human Peripheral Blood-Derived CD133-Positive Cells Stem Cells, April 1, 2009; 27(4): 949 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Zhao, D. Zhang, R. W. Millard, M. Ashraf, and Y. Wang Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1{alpha} delivery and endogenous cytokine signaling Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H976 - H986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tommila, A. Jokilammi, P. Terho, T. Wilson, R. Penttinen, and E. Ekholm Hydroxyapatite coating of cellulose sponges attracts bone-marrow-derived stem cells in rat subcutaneous tissue J R Soc Interface, March 11, 2009; (2009) rsif.2009.0020v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mollmann, H. Nef, A. Elsasser, and C. Hamm Stem cells in myocardial infarction: from bench to bedside Heart, March 1, 2009; 95(6): 508 - 514. [Full Text] [PDF]
|
|
|
|
 |
|
 A.O. Robb, N.L. Mills, I.B.J. Smith, A. Short, O. Tura-Ceide, G.R. Barclay, A. Blomberg, H.O.D. Critchley, D.E. Newby, and F.C. Denison Influence of menstrual cycle on circulating endothelial progenitor cells Hum. Reprod., March 1, 2009; 24(3): 619 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Lucia, A De La Rosa, M A. Silvan, L M Lopez-Mojares, A Boraita, M Perez, C Foster, J Garcia-Castro, and M Ramirez Mobilisation of mesenchymal cells in cardiac patients: is intense exercise necessary? Br. J. Sports Med., March 1, 2009; 43(3): 221 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Bonder, W. Y. Sun, T. Matthews, C. Cassano, X. Li, H. S. Ramshaw, S. M. Pitson, A. F. Lopez, P. T. Coates, R. L. Proia, et al. Sphingosine kinase regulates the rate of endothelial progenitor cell differentiation Blood, February 26, 2009; 113(9): 2108 - 2117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yamahara and H. Itoh Potential use of endothelial progenitor cells for regeneration of the vasculature Therapeutic Advances in Cardiovascular Disease, February 1, 2009; 3(1): 17 - 27. [Abstract] [PDF]
|
|
|
|
 |
|
 Hongling Du and H. S. Taylor Reviews: Stem Cells and Female Reproduction Reproductive Sciences, February 1, 2009; 16(2): 126 - 139. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Rafat, G. Ch. Beck, P. G. Pena-Tapia, P. Schmiedek, and P. Vajkoczy Increased Levels of Circulating Endothelial Progenitor Cells in Patients With Moyamoya Disease Stroke, February 1, 2009; 40(2): 432 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chen, H. Li, F. Addabbo, F. Zhang, E. Pelger, D. Patschan, H.-C. Park, M.-C. Kuo, J. Ni, G. Gobe, et al. Adoptive Transfer of Syngeneic Bone Marrow-Derived Cells in Mice with Obesity-Induced Diabetes: Selenoorganic Antioxidant Ebselen Restores Stem Cell Competence Am. J. Pathol., February 1, 2009; 174(2): 701 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Suzuki, V. Iyer, T. Cimato, and J. M. Canty Jr Pravastatin Improves Function in Hibernating Myocardium by Mobilizing CD133+ and cKit+ Bone Marrow Progenitor Cells and Promoting Myocytes to Reenter the Growth Phase of the Cardiac Cell Cycle Circ. Res., January 30, 2009; 104(2): 255 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Pula, U. Mayr, C. Evans, M. Prokopi, D. S. Vara, X. Yin, Z. Astroulakis, Q. Xiao, J. Hill, Q. Xu, et al. Proteomics Identifies Thymidine Phosphorylase As a Key Regulator of the Angiogenic Potential of Colony-Forming Units and Endothelial Progenitor Cell Cultures Circ. Res., January 2, 2009; 104(1): 32 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Li, A. Vincent, J. Cates, D. M. Brantley-Sieders, D. B. Polk, and P. P. Young Low Levels of Tumor Necrosis Factor {alpha} Increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor Site Cancer Res., January 1, 2009; 69(1): 338 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Desai, A. Glaser, D. Liu, N. Raghavachari, A. Blum, G. Zalos, M. Lippincott, J. P. McCoy, P. J. Munson, M. A. Solomon, et al. Microarray-Based Characterization of a Colony Assay Used to Investigate Endothelial Progenitor Cells and Relevance to Endothelial Function in Humans Arterioscler. Thromb. Vasc. Biol., January 1, 2009; 29(1): 121 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Brunner, G.-H. Schernthaner, M. Satler, M. Elhenicky, F. Hoellerl, K. E. Schmid-Kubista, F. Zeiler, S. Binder, and G. Schernthaner Correlation of Different Circulating Endothelial Progenitor Cells to Stages of Diabetic Retinopathy: First In Vivo Data Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 392 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Obi, K. Yamamoto, N. Shimizu, S. Kumagaya, T. Masumura, T. Sokabe, T. Asahara, and J. Ando Fluid shear stress induces arterial differentiation of endothelial progenitor cells J Appl Physiol, January 1, 2009; 106(1): 203 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Al Mheid and A. A. Quyyumi Cell Therapy in Peripheral Arterial Disease Angiology, January 1, 2009; 59(6): 705 - 716. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Shiba, M. Takahashi, T. Hata, H. Murayama, H. Morimoto, H. Ise, T. Nagasawa, and U. Ikeda Bone marrow CXCR4 induction by cultivation enhances therapeutic angiogenesis Cardiovasc Res, January 1, 2009; 81(1): 169 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Majka, M. Skokan, L. Wheeler, J. Harral, S. Gladson, E. Burnham, J. E. Loyd, K. R. Stenmark, M. Varella-Garcia, and J. West Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension Am J Physiol Lung Cell Mol Physiol, December 1, 2008; 295(6): L1028 - L1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Sussman Showing up Isn't Enough for Vascularization: Persistence Is Essential Circ. Res., November 21, 2008; 103(11): 1200 - 1201. [Full Text] [PDF]
|
|
|
|
|
|
E. C. Keeley, B. Mehrad, and R. M. Strieter Chemokines as Mediators of Neovascularization Arterioscler. Thromb. Vasc. Biol., November 1, 2008; 28(11): 1928 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Murasawa and T. Asahara Review: Cardiogenic potential of endothelial progenitor cells Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 341 - 348. [Abstract] [PDF]
|
|
|
|
|
|
X. Li, Y. Han, W. Pang, C. Li, X. Xie, J. Y.-J. Shyy, and Y. Zhu AMP-Activated Protein Kinase Promotes the Differentiation of Endothelial Progenitor Cells Arterioscler. Thromb. Vasc. Biol., October 1, 2008; 28(10): 1789 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Amos, H. Shang, A. M. Bailey, A. Taylor, A. J. Katz, and S. M. Peirce IFATS Collection: The Role of Human Adipose-Derived Stromal Cells in Inflammatory Microvascular Remodeling and Evidence of a Perivascular Phenotype Stem Cells, October 1, 2008; 26(10): 2682 - 2690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Foubert, G. Matrone, B. Souttou, C. Lere-Dean, V. Barateau, J. Plouet, S. Le Ricousse-Roussanne, B. I. Levy, J.-S. Silvestre, and G. Tobelem Coadministration of Endothelial and Smooth Muscle Progenitor Cells Enhances the Efficiency of Proangiogenic Cell-Based Therapy Circ. Res., September 26, 2008; 103(7): 751 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Stevens, S. Phan, M. G. Frid, D. Alvarez, E. Herzog, and K. R. Stenmark Lung Vascular Cell Heterogeneity: Endothelium, Smooth Muscle, and Fibroblasts Proceedings of the ATS, September 15, 2008; 5(7): 783 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kaneko, K. M. Nishiguchi, M. Nakamura, S. Kachi, and H. Terasaki Characteristics of Bone Marrow-Derived Microglia in the Normal and Injured Retina Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4162 - 4168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Miller, V. Cirulli, G. R. Diaferia, S. Ninniri, G. Hardiman, B. E. Torbett, R. Benezra, and L. Crisa Switching-On Survival and Repair Response Programs in Islet Transplants by Bone Marrow-Derived Vasculogenic Cells Diabetes, September 1, 2008; 57(9): 2402 - 2412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Schroeter, M. Leifheit, P. Sudholt, N.-M. Heida, C. Dellas, I. Rohm, F. Alves, M. Zientkowska, S. Rafail, M. Puls, et al. Leptin Enhances the Recruitment of Endothelial Progenitor Cells Into Neointimal Lesions After Vascular Injury by Promoting Integrin-Mediated Adhesion Circ. Res., August 29, 2008; 103(5): 536 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Suriano, D. Chaudhuri, R. S. Johnson, E. Lambers, B. T. Ashok, R. Kishore, and R. K. Tiwari 17{beta}-Estradiol Mobilizes Bone Marrow-Derived Endothelial Progenitor Cells to Tumors Cancer Res., August 1, 2008; 68(15): 6038 - 6042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Bagley, C. Rouleau, T. St. Martin, P. Boutin, W. Weber, M. Ruzek, N. Honma, M. Nacht, S. Shankara, S. Kataoka, et al. Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248 Mol. Cancer Ther., August 1, 2008; 7(8): 2536 - 2546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Campioni, A. L. Monaco, F. Lanza, S. Moretti, L. Ferrari, M. Fotinidi, R. La Corte, A. Cuneo, and F. Trotta CXCR4pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis Haematologica, August 1, 2008; 93(8): 1233 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Surdacki, E. Marewicz, E. Wieteska, G. Szastak, T. Rakowski, E. Wieczorek-Surdacka, D. Dudek, J. Pryjma, and J. S. Dubiel Association between endothelial progenitor cell depletion in blood and mild-to-moderate renal insufficiency in stable angina Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2265 - 2273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Lee, A. Lyshchik, J. Huamani, D. E. Hallahan, and A. C. Fleischer Relationship Between Retention of a Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-Targeted Ultrasonographic Contrast Agent and the Level of VEGFR2 Expression in an In Vivo Breast Cancer Model J. Ultrasound Med., June 1, 2008; 27(6): 855 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Sun, J. Wu, H. Fujii, J. Wu, S.-H. Li, S. Porozov, A. Belleli, V. Fulga, Y. Porat, and R.-K. Li Human angiogenic cell precursors restore function in the infarcted rat heart: A comparison of cell delivery routes Eur J Heart Fail, June 1, 2008; 10(6): 525 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Chappell, J. Song, A. L. Klibanov, and R. J. Price Ultrasonic Microbubble Destruction Stimulates Therapeutic Arteriogenesis Via the CD18-Dependent Recruitment of Bone Marrow-Derived Cells Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1117 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Mifune, T. Matsumoto, A. Kawamoto, R. Kuroda, T. Shoji, H. Iwasaki, S.-M. Kwon, M. Miwa, M. Kurosaka, and T. Asahara Local Delivery of Granulocyte Colony Stimulating Factor-Mobilized CD34-Positive Progenitor Cells Using Bioscaffold for Modality of Unhealing Bone Fracture Stem Cells, June 1, 2008; 26(6): 1395 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Xu Stem Cells and Transplant Arteriosclerosis Circ. Res., May 9, 2008; 102(9): 1011 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Kalka and I. Baumgartner Gene and stem cell therapy in peripheral arterial occlusive disease Vascular Medicine, May 1, 2008; 13(2): 157 - 172. [Abstract] [PDF]
|
|
|
|
|
|
Y. Tayyareci, M. Sezer, B. Umman, S. Besisik, A. Mudun, Y. Sanli, A. Oncul, N. Gurses, D. Sargin, M. Meric, et al. Intracoronary Autologous Bone Marrow-Derived Mononuclear Cell Transplantation Improves Coronary Collateral Vessel Formation and Recruitment Capacity in Patients With Ischemic Cardiomyopathy: A Combined Hemodynamic and Scintigraphic Approach Angiology, May 1, 2008; 59(2): 145 - 155. [Abstract] [PDF]
|
|
|
|
|
|
K. Chu, K.-H. Jung, S.-T. Lee, H.-K. Park, D.-I. Sinn, J.-M. Kim, D.-H. Kim, J.-H. Kim, S.-J. Kim, E.-C. Song, et al. Circulating Endothelial Progenitor Cells as a New Marker of Endothelial Dysfunction or Repair in Acute Stroke * Supplemental Methods Stroke, May 1, 2008; 39(5): 1441 - 1447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tongers, J.-M. Knapp, M. Korf, T. Kempf, A. Limbourg, F. P. Limbourg, Z. Li, D. Fraccarollo, J. Bauersachs, X. Han, et al. Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hindlimb ischaemia in mice Cardiovasc Res, May 1, 2008; 78(2): 294 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Chavakis, G. Carmona, C. Urbich, S. Gottig, R. Henschler, J. M. Penninger, A. M. Zeiher, T. Chavakis, and S. Dimmeler Phosphatidylinositol-3-Kinase-{gamma} Is Integral to Homing Functions of Progenitor Cells Circ. Res., April 25, 2008; 102(8): 942 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Foteinos, Y. Hu, Q. Xiao, B. Metzler, and Q. Xu Rapid Endothelial Turnover in Atherosclerosis-Prone Areas Coincides With Stem Cell Repair in Apolipoprotein E-Deficient Mice Circulation, April 8, 2008; 117(14): 1856 - 1863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Marsboom, P. Pokreisz, O. Gheysens, P. Vermeersch, H. Gillijns, M. Pellens, X. Liu, D. Collen, and S. Janssens Sustained Endothelial Progenitor Cell Dysfunction After Chronic Hypoxia-Induced Pulmonary Hypertension Stem Cells, April 1, 2008; 26(4): 1017 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Fazel, L. Chen, D. Angoulvant, S.-H. Li, R. D. Weisel, A. Keating, and R.-K. Li Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury FASEB J, March 1, 2008; 22(3): 930 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. Alvarez, L. Huang, J. A. King, M. K. ElZarrad, M. C. Yoder, and T. Stevens Lung microvascular endothelium is enriched with progenitor cells that exhibit vasculogenic capacity Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L419 - L430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tei, T. Matsumoto, Y. Mifune, K. Ishida, K. Sasaki, T. Shoji, S. Kubo, A. Kawamoto, T. Asahara, M. Kurosaka, et al. Administrations of Peripheral Blood CD34-Positive Cells Contribute to Medial Collateral Ligament Healing via Vasculogenesis Stem Cells, March 1, 2008; 26(3): 819 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Carmona, E. Chavakis, U. Koehl, A. M. Zeiher, and S. Dimmeler Activation of Epac stimulates integrin-dependent homing of progenitor cells Blood, March 1, 2008; 111(5): 2640 - 2646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Duvall, D. Weiss, S. T. Robinson, F. M.F. Alameddine, R. E. Guldberg, and W. R. Taylor The Role of Osteopontin in Recovery from Hind Limb Ischemia Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 290 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Rafii, B. Psaila, J. Butler, D. K. Jin, and D. Lyden Regulation of Vasculogenesis by Platelet-Mediated Recruitment of Bone Marrow-Derived Cells Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 217 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tang, J. Lu, J. P. Walterscheid, H.-H. Chen, D. A. Engler, T. Sawamura, P.-Y. Chang, H. J. Safi, C.-Y. Yang, and C.-H. Chen Electronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1 J. Lipid Res., January 1, 2008; 49(1): 33 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-K. Yip, L.-T. Chang, W.-N. Chang, C.-H. Lu, C.-W. Liou, M.-Y. Lan, J. S. Liu, A. A. Youssef, and H.-W. Chang Level and Value of Circulating Endothelial Progenitor Cells in Patients After Acute Ischemic Stroke Stroke, January 1, 2008; 39(1): 69 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lefevre, S.-E. Michaud, P. Haddad, S. Dussault, C. Menard, J. Groleau, J. Turgeon, and A. Rivard Moderate consumption of red wine (cabernet sauvignon) improves ischemia-induced neovascularization in ApoE-deficient mice: effect on endothelial progenitor cells and nitric oxide FASEB J, December 1, 2007; 21(14): 3845 - 3852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Grenier, A. Scime, F. Le Grand, A. Asakura, C. Perez-Iratxeta, M. A. Andrade-Navarro, P. A. Labosky, and M. A. Rudnicki Resident Endothelial Precursors in Muscle, Adipose, and Dermis Contribute to Postnatal Vasculogenesis Stem Cells, December 1, 2007; 25(12): 3101 - 3110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kumin, M. Schafer, N. Epp, P. Bugnon, C. Born-Berclaz, A. Oxenius, A. Klippel, W. Bloch, and S. Werner Peroxiredoxin 6 is required for blood vessel integrity in wounded skin J. Cell Biol., November 19, 2007; 179(4): 747 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kanayasu-Toyoda, A. Ishii-Watabe, T. Suzuki, T. Oshizawa, and T. Yamaguchi A New Role of Thrombopoietin Enhancing ex Vivo Expansion of Endothelial Precursor Cells Derived from AC133-positive Cells J. Biol. Chem., November 16, 2007; 282(46): 33507 - 33514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Farha, K. Asosingh, D. Laskowski, L. Licina, H. Sekigushi, D. W. Losordo, R. A. Dweik, H. P. Wiedemann, and S. C. Erzurum Pulmonary gas transfer related to markers of angiogenesis during the menstrual cycle J Appl Physiol, November 1, 2007; 103(5): 1789 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tongers and D. W. Losordo Frontiers in Nephrology: The Evolving Therapeutic Applications of Endothelial Progenitor Cells J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2843 - 2852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. B. Slayton, X.-M. Li, J. Butler, S. M. Guthrie, M. L. Jorgensen, J. R. Wingard, and E. W. Scott The Role of the Donor in the Repair of the Marrow Vascular Niche Following Hematopoietic Stem Cell Transplant Stem Cells, November 1, 2007; 25(11): 2945 - 2955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jost, C. Maillard, J. Lecomte, V. Lambert, M. Tjwa, P. Blaise, M.-L. Alvarez Gonzalez, K. Bajou, S. Blacher, P. Motte, et al. Tumoral and Choroidal Vascularization: Differential Cellular Mechanisms Involving Plasminogen Activator Inhibitor Type I Am. J. Pathol., October 1, 2007; 171(4): 1369 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Masuda, C. Kalka, T. Takahashi, M. Yoshida, M. Wada, M. Kobori, R. Itoh, H. Iwaguro, M. Eguchi, Y. Iwami, et al. Estrogen-Mediated Endothelial Progenitor Cell Biology and Kinetics For Physiological Postnatal Vasculogenesis Circ. Res., September 14, 2007; 101(6): 598 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Shmilovich, V. Deutsch, A. Roth, H. Miller, G. Keren, and J. George Circulating endothelial progenitor cells in patients with cardiac syndrome X Heart, September 1, 2007; 93(9): 1071 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Morimoto, M. Takahashi, Y. Shiba, A. Izawa, H. Ise, M. Hongo, K. Hatake, K. Motoyoshi, and U. Ikeda Bone Marrow-Derived CXCR4+ Cells Mobilized by Macrophage Colony-Stimulating Factor Participate in the Reduction of Infarct Area and Improvement of Cardiac Remodeling after Myocardial Infarction in Mice Am. J. Pathol., September 1, 2007; 171(3): 755 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Zaca, S. Rastogi, M. Imai, M. Wang, V. G. Sharov, A. Jiang, S. Goldstein, and H. N. Sabbah Chronic Monotherapy With Rosuvastatin Prevents Progressive Left Ventricular Dysfunction and Remodeling in Dogs With Heart Failure J. Am. Coll. Cardiol., August 7, 2007; 50(6): 551 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Rademaker-Lakhai, L. V. Beerepoot, N. Mehra, S. A. Radema, R. van Maanen, J. S. Vermaat, E. O. Witteveen, C. M. Visseren-Grul, L. Musib, N. Enas, et al. Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C {beta}-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer Clin. Cancer Res., August 1, 2007; 13(15): 4474 - 4481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schmidt, K. Brixius, and W. Bloch Endothelial Precursor Cell Migration During Vasculogenesis Circ. Res., July 20, 2007; 101(2): 125 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Vartanian and R. Sarkar Therapeutic Angiogenesis Vascular and Endovascular Surgery, July 1, 2007; 41(3): 173 - 185. [Abstract] [PDF]
|
|
|
|
|
|
G. Pasquinelli, P. L. Tazzari, C. Vaselli, L. Foroni, M. Buzzi, G. Storci, F. Alviano, F. Ricci, M. Bonafe, C. Orrico, et al. Thoracic Aortas from Multiorgan Donors Are Suitable for Obtaining Resident Angiogenic Mesenchymal Stromal Cells Stem Cells, July 1, 2007; 25(7): 1627 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Iwasaki, K. Fukushima, A. Kawamoto, K. Umetani, A. Oyamada, S. Hayashi, T. Matsumoto, M. Ishikawa, T. Shibata, H. Nishimura, et al. Synchrotron Radiation Coronary Microangiography for Morphometric and Physiological Evaluation of Myocardial Neovascularization Induced by Endothelial Progenitor Cell Transplantation Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1326 - 1333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ishii, T.-K. Ito, K. Aoyagi, H. Fujimoto, H. Chiba, T. Hasebe, S. Fujii, K. Nagai, H. Sasaki, and A. Ochiai Presence of Human Circulating Progenitor Cells for Cancer Stromal Fibroblasts in the Blood of Lung Cancer Patients Stem Cells, June 1, 2007; 25(6): 1469 - 1477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Invernici, C. Emanueli, P. Madeddu, S. Cristini, S. Gadau, A. Benetti, E. Ciusani, G. Stassi, M. Siragusa, R. Nicosia, et al. Human Fetal Aorta Contains Vascular Progenitor Cells Capable of Inducing Vasculogenesis, Angiogenesis, and Myogenesis in Vitro and in a Murine Model of Peripheral Ischemia Am. J. Pathol., June 1, 2007; 170(6): 1879 - 1892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-K. Oh, J.-M. Ha, E. O, B. H. Lee, S. K. Lee, B.-S. Shim, Y.-K. Hong, and Y. A. Joe Tumor Angiogenesis Promoted by Ex vivo Differentiated Endothelial Progenitor Cells Is Effectively Inhibited by an Angiogenesis Inhibitor, TK1-2 Cancer Res., May 15, 2007; 67(10): 4851 - 4859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Balasubramaniam, C. F. Mervis, A. M. Maxey, N. E. Markham, and S. H. Abman Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1073 - L1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Pisati, M. Belicchi, F. Acerbi, C. Marchesi, C. Giussani, M. Gavina, S. Javerzat, M. Hagedorn, G. Carrabba, V. Lucini, et al. Effect of Human Skin-Derived Stem Cells on Vessel Architecture, Tumor Growth, and Tumor Invasion in Brain Tumor Animal Models Cancer Res., April 1, 2007; 67(7): 3054 - 3063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Caballero, N. Sengupta, A. Afzal, K.-H. Chang, S. Li Calzi, D. L. Guberski, T. S. Kern, and M. B. Grant Ischemic Vascular Damage Can Be Repaired by Healthy, but Not Diabetic, Endothelial Progenitor Cells Diabetes, April 1, 2007; 56(4): 960 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Oki and A. Younes Endothelial progenitor cells in non-Hodgkin's lymphoma Haematologica, April 1, 2007; 92(4): 433 - 434. [Full Text] [PDF]
|
|
|
|
|
|
C. Igreja, M. Courinha, A. S. Cachaco, T. Pereira, J. Cabecadas, M. G. da Silva, and S. Dias Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients Haematologica, April 1, 2007; 92(4): 469 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sumi, M. Sata, S.-i. Miura, K.-A. Rye, N. Toya, Y. Kanaoka, K. Yanaga, T. Ohki, K. Saku, and R. Nagai Reconstituted High-Density Lipoprotein Stimulates Differentiation of Endothelial Progenitor Cells and Enhances Ischemia-Induced Angiogenesis Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 813 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nakano, K. Satoh, Y. Fukumoto, Y. Ito, Y. Kagaya, N. Ishii, K. Sugamura, and H. Shimokawa Important Role of Erythropoietin Receptor to Promote VEGF Expression and Angiogenesis in Peripheral Ischemia in Mice Circ. Res., March 16, 2007; 100(5): 662 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aicher, M. Rentsch, K.-i. Sasaki, J. W. Ellwart, F. Fandrich, R. Siebert, J. P. Cooke, S. Dimmeler, and C. Heeschen Nonbone Marrow-Derived Circulating Progenitor Cells Contribute to Postnatal Neovascularization Following Tissue Ischemia Circ. Res., March 2, 2007; 100(4): 581 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tran, P. R. Franken, F. Maskali, J. Nloga, P. Maureira, S. Poussier, F. Groubatch, C. Vanhove, J.-P. Villemot, and P.-Y. Marie Intramyocardial Implantation of Bone Marrow-Derived Stem Cells Enhances Perfusion in Chronic Myocardial Infarction: Dependency on Initial Perfusion Depth and Follow-up Assessed by Gated Pinhole SPECT J. Nucl. Med., March 1, 2007; 48(3): 405 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Thum, D. Fraccarollo, M. Schultheiss, S. Froese, P. Galuppo, J. D. Widder, D. Tsikas, G. Ertl, and J. Bauersachs Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes Diabetes, March 1, 2007; 56(3): 666 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nishiwaki, M. Yoshida, H. Iwaguro, H. Masuda, N. Nitta, T. Asahara, and M. Isobe Endothelial E-Selectin Potentiates Neovascularization via Endothelial Progenitor Cell-Dependent and -Independent Mechanisms Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 512 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tan, H. Shao, D. Eton, Z. Yang, L. Alonso-Diaz, H. Zhang, A. Schulick, A. S. Livingstone, and H. Yu Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor Cardiovasc Res, March 1, 2007; 73(4): 823 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Shantsila, T. Watson, and G. Y.H. Lip Endothelial Progenitor Cells in Cardiovascular Disorders J. Am. Coll. Cardiol., February 20, 2007; 49(7): 741 - 752. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||